IN2014MN00952A - - Google Patents
Info
- Publication number
- IN2014MN00952A IN2014MN00952A IN952MUN2014A IN2014MN00952A IN 2014MN00952 A IN2014MN00952 A IN 2014MN00952A IN 952MUN2014 A IN952MUN2014 A IN 952MUN2014A IN 2014MN00952 A IN2014MN00952 A IN 2014MN00952A
- Authority
- IN
- India
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011285970A JP5318938B2 (ja) | 2011-06-09 | 2011-12-27 | ジフェニルメチルピペラジン誘導体、及びそれを用いた医薬組成物 |
PCT/JP2012/003946 WO2013099048A1 (ja) | 2011-12-27 | 2012-06-15 | ジフェニルメチルピペラジン誘導体、及びそれを用いた医薬組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014MN00952A true IN2014MN00952A (ja) | 2015-05-01 |
Family
ID=48699401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN952MUN2014 IN2014MN00952A (ja) | 2011-12-27 | 2014-05-21 |
Country Status (10)
Country | Link |
---|---|
US (1) | US9073861B2 (ja) |
EP (2) | EP2799430B1 (ja) |
JP (1) | JP5318938B2 (ja) |
KR (1) | KR101963724B1 (ja) |
CN (1) | CN103998428B (ja) |
AU (1) | AU2012359927B2 (ja) |
CA (1) | CA2855919C (ja) |
IN (1) | IN2014MN00952A (ja) |
TW (1) | TWI532723B (ja) |
WO (1) | WO2013099048A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6021616B2 (ja) * | 2012-12-04 | 2016-11-09 | 株式会社アエタスファルマ | 3−ピペラジニル−1−ピペリジニル−プロパン誘導体及びそれを含有してなる医薬組成物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU198052B (en) * | 1986-02-14 | 1989-07-28 | Sandoz Ag | Process for producing purine derivatives substituted by side chain containing piperazinyl ring and pharmaceutical compositions comprising such compounds |
JP2651043B2 (ja) * | 1990-07-10 | 1997-09-10 | 麒麟麦酒株式会社 | ジフェニルメチルピペラジン誘導体 |
JP4152576B2 (ja) * | 1999-09-30 | 2008-09-17 | 昇 金子 | 抗がん剤 |
CA2385996C (en) * | 1999-09-30 | 2008-02-12 | Noboru Kaneko | Anticancer agents |
AU2004240842B2 (en) * | 2003-05-21 | 2009-11-05 | Aska Pharmaceutical Co., Ltd. | Cyclicamino-Phenyl Sulfamate Derivatives |
-
2011
- 2011-12-27 JP JP2011285970A patent/JP5318938B2/ja active Active
-
2012
- 2012-06-15 EP EP12861236.3A patent/EP2799430B1/en not_active Ceased
- 2012-06-15 AU AU2012359927A patent/AU2012359927B2/en not_active Ceased
- 2012-06-15 CN CN201280062663.5A patent/CN103998428B/zh not_active Expired - Fee Related
- 2012-06-15 KR KR1020147014761A patent/KR101963724B1/ko active IP Right Grant
- 2012-06-15 US US14/359,519 patent/US9073861B2/en active Active
- 2012-06-15 WO PCT/JP2012/003946 patent/WO2013099048A1/ja active Application Filing
- 2012-06-15 EP EP16171164.3A patent/EP3091001B1/en not_active Not-in-force
- 2012-06-15 CA CA2855919A patent/CA2855919C/en not_active Expired - Fee Related
- 2012-06-26 TW TW101122754A patent/TWI532723B/zh not_active IP Right Cessation
-
2014
- 2014-05-21 IN IN952MUN2014 patent/IN2014MN00952A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2013014569A (ja) | 2013-01-24 |
EP2799430A4 (en) | 2015-05-13 |
TWI532723B (zh) | 2016-05-11 |
US20140296253A1 (en) | 2014-10-02 |
EP2799430B1 (en) | 2016-07-20 |
CN103998428B (zh) | 2016-03-23 |
CA2855919C (en) | 2019-06-04 |
AU2012359927A1 (en) | 2014-05-29 |
TW201326123A (zh) | 2013-07-01 |
EP3091001B1 (en) | 2017-11-22 |
KR20140114339A (ko) | 2014-09-26 |
JP5318938B2 (ja) | 2013-10-16 |
WO2013099048A1 (ja) | 2013-07-04 |
AU2012359927B2 (en) | 2017-03-09 |
KR101963724B1 (ko) | 2019-03-29 |
CN103998428A (zh) | 2014-08-20 |
EP3091001A1 (en) | 2016-11-09 |
US9073861B2 (en) | 2015-07-07 |
EP2799430A1 (en) | 2014-11-05 |
CA2855919A1 (en) | 2013-07-04 |